Xiao-yuan Liu

发表

Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells

Jin-Ming Yang, Z. Qin, Yi Zhang, 2011, Acta Pharmacologica Sinica.

Preclinical Development MK-2206 , a Novel Allosteric Inhibitor of Akt , Synergizes with Ge fi tinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis

J. Liao, Jin-Ming Yang, X. Ren, 2011 .

MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis

J. Liao, Jin-Ming Yang, X. Ren, 2011, Molecular Cancer Therapeutics.

The central nervous system can directly regulate breast cancer progression and blockage by quercetin

Hai Lu, Qianjun Chen, Xiao-yuan Liu, 2021, Annals of translational medicine.

Acupuncture for Breast Cancer: A Systematic Review and Meta-Analysis of Patient-Reported Outcomes

Hai Lu, Hongyan Zhang, Qianjun Chen, 2021, Frontiers in Oncology.

Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide against Glioma

Jin-Ming Yang, Yi Zhang, Jianping Wu, 2013, PloS one.

Network Pharmacology–Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells

Ji-Rong Wen, Dong-mei Li, Hai Lu, 2021, Frontiers in Pharmacology.

MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis

J. Liao, Jin-Ming Yang, X. Ren, 2011, Molecular Cancer Therapeutics.